Intrinsiqq
BB Biotech AG logo

BB Biotech AG

BB.XMIL

Compare

Profitability & Returns

Revenue (TTM)

CHF 809M

▲ +613.1% YoY

Net Income (TTM)

CHF 798M

▲ +661.7% YoY

Op. Margin

–

ROIC

–

Cash Flow & Balance Sheet

FCF (TTM)

CHF 394M

▲ +1.5% YoY

Op. Cash Flow (TTM)

CHF 394M

▲ +1.5% YoY

Net Debt

-CHF 98M

Net Cash Position

Cash & Equiv.

CHF 98M

3Y CAGR: +10.2%

Continue Research

Held by ETFs

BB.XMIL is in 1 US ETF. The largest of them, with BB.XMIL's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BB.XMIL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.